Franklin Resources’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $172K | Sell |
10,268
-670
| -6% | -$12K | ﹤0.01% | 2822 |
|
|
2025
Q4 | $175K | Sell |
10,938
-8,433
| -44% | -$126K | ﹤0.01% | 2820 |
|
|
2025
Q3 | $239K | Sell |
19,371
-4,397
| -18% | -$51.5K | ﹤0.01% | 2761 |
|
|
2025
Q2 | $274K | Sell |
23,768
-3,791
| -14% | -$45K | ﹤0.01% | 2599 |
|
|
2025
Q1 | $413K | Buy |
27,559
+782
| +3% | +$13.1K | ﹤0.01% | 2342 |
|
|
2024
Q4 | $464K | Buy |
+26,777
| New | +$517K | ﹤0.01% | 2320 |
|
|
2019
Q4 | – | Sell |
-1,165,690
| Closed | -$54.3M | – | 1536 |
|
|
2019
Q3 | $54.3M | Buy |
1,165,690
+18,470
| +2% | +$859K | 0.03% | 514 |
|
|
2019
Q2 | $60M | Buy |
1,147,220
+320,165
| +39% | +$18.8M | 0.03% | 506 |
|
|
2019
Q1 | $57M | Buy |
827,055
+87,215
| +12% | +$5.85M | 0.03% | 499 |
|
|
2018
Q4 | $44.1M | Buy |
739,840
+268,240
| +57% | +$23.1M | 0.03% | 503 |
|
|
2018
Q3 | $54.6M | Buy |
471,600
+10,600
| +2% | +$1.2M | 0.03% | 516 |
|
|
2018
Q2 | $58.2M | Sell |
461,000
-9,800
| -2% | -$1.19M | 0.03% | 495 |
|
|
2018
Q1 | $51M | Sell |
470,800
-19,466
| -4% | -$2.15M | 0.03% | 527 |
|
|
2017
Q4 | $53.7M | Buy |
490,266
+12,866
| +3% | +$1.28M | 0.03% | 516 |
|
|
2017
Q3 | $47.1M | Buy |
477,400
+116,300
| +32% | +$11.3M | 0.02% | 549 |
|
|
2017
Q2 | $36.6M | Sell |
361,100
-73,105
| -17% | -$7.88M | 0.02% | 621 |
|
|
2017
Q1 | $50.2M | Sell |
434,205
-197,400
| -31% | -$22.9M | 0.03% | 518 |
|
|
2016
Q4 | $75.8M | Buy |
631,605
+51,600
| +9% | +$5.71M | 0.04% | 422 |
|
|
2016
Q3 | $65.2M | Buy |
580,005
+7,500
| +1% | +$864K | 0.03% | 448 |
|
|
2016
Q2 | $70.9M | Sell |
572,505
-27,595
| -5% | -$3.33M | 0.04% | 436 |
|
|
2016
Q1 | $67.5M | Buy |
600,100
+1,600
| +0.3% | +$166K | 0.04% | 448 |
|
|
2015
Q4 | $65.1M | Buy |
598,500
+28,800
| +5% | +$3.3M | 0.03% | 479 |
|
|
2015
Q3 | $56.9M | Buy |
569,700
+58,100
| +11% | +$6.32M | 0.03% | 515 |
|
|
2015
Q2 | $58.3M | Buy |
+511,600
| New | +$62M | 0.03% | 551 |
|
|
2014
Q4 | – | Sell |
-50,000
| Closed | -$7.32M | – | 1578 |
|
|
2014
Q3 | $7.32M | Sell |
50,000
-25,000
| -33% | -$3.86M | ﹤0.01% | 1104 |
|
|
2014
Q2 | $12.5M | Buy |
75,000
+4,900
| +7% | +$872K | 0.01% | 1005 |
|
|
2014
Q1 | $13.9M | Buy |
70,100
+20,000
| +40% | +$3.78M | 0.01% | 947 |
|
|
2013
Q4 | $9.57M | Hold |
50,100
| – | – | ﹤0.01% | 996 |
|
|
2013
Q3 | $8.48M | Buy |
50,100
+100
| +0.2% | +$15.5K | ﹤0.01% | 1013 |
|
|
2013
Q2 | $7.58M | Buy |
+50,000
| New | +$7.08M | ﹤0.01% | 1005 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Franklin Resources's CLB Position: Q1 2026 in Review
Franklin Resources reduced its Core Laboratories (CLB) stake by 6.1% in Q1 2026, selling an estimated $12K and leaving 10,268 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2822.
Franklin Resources first reported a position in CLB in Q2 2013 and has held it in 30 quarters since. The position peaked at $75.8M in Q4 2016. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Franklin Resources held 10,268 shares of Core Laboratories worth $172K as of Q1 2026.
- Franklin Resources sold 670 Core Laboratories shares in Q1 2026, an estimated $12K.
- Core Laboratories made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2822 holding.
- Franklin Resources first reported a position in Core Laboratories in Q2 2013 and has held it in 30 quarters since.
- Franklin Resources's Core Laboratories position peaked at $75.8M in Q4 2016.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.